Article Details
Retrieved on: 2024-07-12 19:21:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer selected Danuglipron, its once-daily weight loss drug, for continued advancement based on an ongoing pharmacokinetic study.
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here